2015
DOI: 10.1016/j.ijporl.2015.04.032
|View full text |Cite
|
Sign up to set email alerts
|

E-cigarettes: Considerations for the otolaryngologist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…The concerns with this is the fact that all three of these are carcinogenic compounds and while present in e-cigarettes exist at lesser levels (9-450 times lower) than in tobacco-based cigarettes although nicotine content may be significantly higher in what has been branded a 'risk free' alternative. 15,26 Moreover, the vehicle fluids, for example, propylene glycol and glycerine, have been shown to impair lung function through increased respiratory impedance and can be associated with dry throat and cough and in some cases airway obstruction with an objective reversible reduction in forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio of 3% having been noted upon acute use. Unsurprisingly, this could be more significant in patients who have background COPD/asthma.…”
Section: Safetymentioning
confidence: 99%
See 1 more Smart Citation
“…The concerns with this is the fact that all three of these are carcinogenic compounds and while present in e-cigarettes exist at lesser levels (9-450 times lower) than in tobacco-based cigarettes although nicotine content may be significantly higher in what has been branded a 'risk free' alternative. 15,26 Moreover, the vehicle fluids, for example, propylene glycol and glycerine, have been shown to impair lung function through increased respiratory impedance and can be associated with dry throat and cough and in some cases airway obstruction with an objective reversible reduction in forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio of 3% having been noted upon acute use. Unsurprisingly, this could be more significant in patients who have background COPD/asthma.…”
Section: Safetymentioning
confidence: 99%
“…Prior to this they were freely available from online and market vendors with over 400 brands and >7000 flavours of e-cigarettes now thought to exist each with a very different chemical profile and constitution. 15 As such, clear knowledge of the evidence and toxicology of these agents is required by the responsible clinician, who is likely to encounter their use within patients of different specialities, and in those who wish to stop smoking. 16 It is because of this meteoric rise in popularity of e-cigarettes that as a profession we are playing catch up trying to synthesise evidence regarding an already marketed product.…”
Section: Introductionmentioning
confidence: 99%
“…Significant headway has been made in assessing the effect of e‐cig components on the respiratory and cardiovascular systems, 16 , 17 , 18 , 19 , 20 , 21 , 22 and the number of studies exploring the effects of e‐cigs on other organ systems has also recently grown. 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 …”
mentioning
confidence: 99%
“…On PubMed alone, the number of published articles on e‐cigs has increased from 372 in 2014 to 1132 in 2021 and there are hundreds of review papers on various aspects of e‐cig use. Significant headway has been made in assessing the effect of e‐cig components on the respiratory and cardiovascular systems, 16‐22 and the number of studies exploring the effects of e‐cigs on other organ systems has also recently grown 23‐46 …”
mentioning
confidence: 99%